Active Pharmaceutical Ingredient (API)
Mavacamten
Cardiac Myosin Inhibitor
Targeted therapy for obstructive hypertrophic cardiomyopathy (HCM). It reduces the number of myosin-actin cross-bridges to relieve outflow tract obstruction.
Technical Profile
- Reference Code
- Crd947
- CAS Number
- 1642288-49-4
- Molecular Weight
- 273.33 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C15H19N3O2
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Mavacamten as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||